On 1 July, nearly 300 laboratory staff from across the globe - both in-person and online -gathered for our inaugural IHH Labs Town Hall.
This landmark event united our lab entities, including Premier Integrated Labs (Malaysia), Parkway Laboratories (Singapore), Acibadem Labmed (Turkiye), and Agilus Diagnostics (India), as we harness our strengths, partnerships, and capabilities to create value for our patients and partners.
In his welcome address, IHH Group CEO Dr Prem Kumar Nair praised our Labs colleagues for their dedication in shaping our vision of becoming the world’s top medical laboratory service provider.
“Let me just say how incredibly proud I am of everything we've achieved together. In just a few short years, we’ve built a global lab business that’s not only thriving but also stands as a key growth pillar of IHH Healthcare. This success story is all thanks to your hard work, dedication, and unwavering commitment to excellence. As we gather here today, I can’t help but feel a surge of excitement about our future. We’re at a pivotal moment, not just for our labs but for IHH Healthcare as a whole,” said Dr Prem.
Ashok Pandit, IHH Group Chief Corporate Officer, shared our long-term strategy for building our laboratory business.
“Our big focus is to prime our laboratory business as a distinct core business and new growth engine for IHH Healthcare, increase our market share with high-end tests and position ourselves as a regional reference laboratory in Asia,” he said.
Next, a dynamic fireside chat featuring Ashok Pandit, IHH Group Chief Corporate Officer, Prof Dr Ibrahim Unsal, COO and Chief Medical Officer of IHH Laboratories; Hareeff Muhammed, CEO of Premier Integrated Labs; Dr Shawn Ng, CEO of Parkway Laboratories; Prof Dr Mustafa Serteser, CEO of Acibadem Labmed; and Anand K, CEO of Agilus Diagnostics, moderated by Janet Low, Group Head of Communications & Branding, delved into the unique aspects, staff integration efforts, digital initiatives and upcoming plans of each lab entity.
Pauline Puay, Chief People Officer at IHH Laboratories, rounded up the townhall by emphasising IHH’s commitment to empower our teams to innovate, lead and transform healthcare.
Related Stories
Transforming Our Future: A Decade of Quality & Safety
The 10th IHH Healthcare Quality Summit 2025 in Hong Kong brought together more than 200 leaders, clinicians and quality champions from across our global network to reaffirm our commitment to clinical excellence, patient safety, and transformative care.
Pantai Hospital Kuala Lumpur Powers Malaysia’s Biggest Marathon with Heart
Every effort counts with a record-breaking 42,000 participants registering for the 17th edition of Malaysia’s premier distance running event.
Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care
Step inside a new era of connected, technology-enabled care designed around patients’ needs.
.png?sfvrsn=3ba27871_1)
Celebrating the D.N.A. of Excellence across IHH Labs
The recent IHH Labs Townhall was especially meaningful as we celebrated the achievements of our medical technologists - the very backbone of IHH Laboratories - through the launch of the Global IHH Labs D.N.A. Award, which stands for Discovery, Nurturing, and Accuracy.
IHH Healthcare Shines at The Economic Times Healthcare Awards 2025
Explore the award-winning care and innovation across our network.
Gleneagles Hospital Chennai Propels the Frontier of Advanced Cancer Care and Robotic Oncology
On 27 September, over 300 delegates converge to exchange knowledge and deliberate on advanced cancer surgery, robotic oncology, head and neck oncology, radiation therapy, and supportive care.
